Last reviewed · How we verify

High-dose furosemide

Larissa University Hospital · FDA-approved active Small molecule ✓ Verified May 2026 Quality 2/100

High-dose furosemide is a Small molecule drug developed by Larissa University Hospital. It is currently FDA-approved.

High-dose furosemide is used to treat various conditions, including Heart Failure, Hematological Malignancy, Pre-Eclampsia, Hypertension in Pregnancy, and Pregnancy Complications, as indicated by ClinicalTrials.gov. Furosemide works by inhibiting the sodium-(potassium)-chloride cotransporter 2, as verified by ChEMBL.

At a glance

Generic nameHigh-dose furosemide
SponsorLarissa University Hospital
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about High-dose furosemide

What is High-dose furosemide?

High-dose furosemide is a Small molecule drug developed by Larissa University Hospital.

Who makes High-dose furosemide?

High-dose furosemide is developed and marketed by Larissa University Hospital (see full Larissa University Hospital pipeline at /company/larissa-university-hospital).

What development phase is High-dose furosemide in?

High-dose furosemide is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing